Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ropivacaine for episiotomy analgesia
2016-002786-62Phase 3Active
- Sponsor
- CHD Vendée
- Start
- May 2017
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of ropivacaine in episiotomy pain, sponsored by CHD Vendée. Started May 2017; status: active.
02
Drugs
ropivacaine
03
Conditions
episiotomy pain
Beyond the preview
Go deeper on 2016-002786-62.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-002786-62.